No Prescription |
 |
 | ||
|
Captopril Apo Generic Capoten |
|
| ||
No Prescription » Prescription Drugs 3 » Captopril Apo Generic Capoten This drug belongs to a group of medications called ACE inhibitors. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels causing them to widen. Lowering high blood pressure helps prevent strokes heart attacks and kidney problems.This medication is also used to improve survival after an acute heart attack help protect the kidneys from damage due to diabetes and with other drugs (e.g. "water pills"/diuretics digoxin) to treat congestive heart failure.How to use Captopril OralTake this medication by mouth usually two to three times a day; or as directed by your doctor. Take this drug on an empty stomach one hour before a meal. Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time(s) each day.Do not take potassium supplements or salt substitutes containing potassium without talking to your doctor or pharmacist first. This medicine can raise your potassium levels which rarely can cause serious side effects such as muscle weakness or very slow heartbeats. Tell your doctor immediately if these effects occur.The dosage is based on your medical condition and response to therapy. For the treatment of high blood pressure it may take 2 to 4 weeks before the full benefit of this drug occurs or several weeks to months when used for congestive heart failure.It is important to continue taking this medication even if you feel well. Most people with high blood pressure do not feel sick. Buy Captopril Apo Generic Capoten and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Captopril Apo Generic Capoten: Product Type: Prescription Drugs 3 Captopril Apo ( Generic Capoten ) Captopril Apo (Generic Capoten) Generic Capoten 12.5mg 500 Tabs 25mg 50mg Generic Capoten Captopril Apo
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
